Taiwan · Delayed Price · Currency is TWD Li Kang Biomedical Statistics
Total Valuation
TPEX:6242 has a market cap or net worth of TWD 1.20 billion. The enterprise value is 1.14 billion.
| Market Cap | 1.20B |
| Enterprise Value | 1.14B |
Important Dates
The next estimated earnings date is Friday, August 7, 2026.
| Earnings Date | Aug 7, 2026 |
| Ex-Dividend Date | Jun 16, 2025 |
Share Statistics
TPEX:6242 has 31.81 million shares outstanding. The number of shares has decreased by -0.47% in one year.
| Current Share Class | 31.81M |
| Shares Outstanding | 31.81M |
| Shares Change (YoY) | -0.47% |
| Shares Change (QoQ) | -0.93% |
| Owned by Insiders (%) | 3.78% |
| Owned by Institutions (%) | n/a |
| Float | 12.62M |
Valuation Ratios
The trailing PE ratio is 15.47.
| PE Ratio | 15.47 |
| Forward PE | n/a |
| PS Ratio | 2.08 |
| PB Ratio | 1.36 |
| P/TBV Ratio | 1.36 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 17.00 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 11.52, with an EV/FCF ratio of -4.69.
| EV / Earnings | 14.73 |
| EV / Sales | 1.98 |
| EV / EBITDA | 11.52 |
| EV / EBIT | 12.48 |
| EV / FCF | -4.69 |
Financial Position
The company has a current ratio of 1.57, with a Debt / Equity ratio of 0.14.
| Current Ratio | 1.57 |
| Quick Ratio | 1.21 |
| Debt / Equity | 0.14 |
| Debt / EBITDA | 1.27 |
| Debt / FCF | -0.52 |
| Interest Coverage | 254.26 |
Financial Efficiency
Return on equity (ROE) is 8.86% and return on invested capital (ROIC) is 9.04%.
| Return on Equity (ROE) | 8.86% |
| Return on Assets (ROA) | 5.24% |
| Return on Invested Capital (ROIC) | 9.04% |
| Return on Capital Employed (ROCE) | 9.79% |
| Weighted Average Cost of Capital (WACC) | 3.74% |
| Revenue Per Employee | 4.72M |
| Profits Per Employee | 635,762 |
| Employee Count | 122 |
| Asset Turnover | 0.53 |
| Inventory Turnover | 3.73 |
Taxes
In the past 12 months, TPEX:6242 has paid 18.68 million in taxes.
| Income Tax | 18.68M |
| Effective Tax Rate | 19.41% |
Stock Price Statistics
The stock price has decreased by -12.33% in the last 52 weeks. The beta is -0.03, so TPEX:6242's price volatility has been lower than the market average.
| Beta (5Y) | -0.03 |
| 52-Week Price Change | -12.33% |
| 50-Day Moving Average | 37.78 |
| 200-Day Moving Average | 39.49 |
| Relative Strength Index (RSI) | 46.91 |
| Average Volume (20 Days) | 10,155 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, TPEX:6242 had revenue of TWD 575.98 million and earned 77.56 million in profits. Earnings per share was 2.44.
| Revenue | 575.98M |
| Gross Profit | 388.18M |
| Operating Income | 91.53M |
| Pretax Income | 96.24M |
| Net Income | 77.56M |
| EBITDA | 99.15M |
| EBIT | 91.53M |
| Earnings Per Share (EPS) | 2.44 |
Balance Sheet
The company has 182.99 million in cash and 126.29 million in debt, with a net cash position of 56.69 million or 1.78 per share.
| Cash & Cash Equivalents | 182.99M |
| Total Debt | 126.29M |
| Net Cash | 56.69M |
| Net Cash Per Share | 1.78 |
| Equity (Book Value) | 881.47M |
| Book Value Per Share | 27.71 |
| Working Capital | 90.43M |
Cash Flow
In the last 12 months, operating cash flow was 70.56 million and capital expenditures -314.35 million, giving a free cash flow of -243.79 million.
| Operating Cash Flow | 70.56M |
| Capital Expenditures | -314.35M |
| Depreciation & Amortization | 7.61M |
| Net Borrowing | 33.02M |
| Free Cash Flow | -243.79M |
| FCF Per Share | -7.66 |
Margins
Gross margin is 67.40%, with operating and profit margins of 15.89% and 13.47%.
| Gross Margin | 67.40% |
| Operating Margin | 15.89% |
| Pretax Margin | 16.71% |
| Profit Margin | 13.47% |
| EBITDA Margin | 17.21% |
| EBIT Margin | 15.89% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 2.00, which amounts to a dividend yield of 5.33%.
| Dividend Per Share | 2.00 |
| Dividend Yield | 5.33% |
| Dividend Growth (YoY) | -20.00% |
| Years of Dividend Growth | n/a |
| Payout Ratio | 82.01% |
| Buyback Yield | 0.47% |
| Shareholder Yield | 5.82% |
| Earnings Yield | 6.47% |
| FCF Yield | -20.33% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on June 30, 2023. It was a forward split with a ratio of 1.15.
| Last Split Date | Jun 30, 2023 |
| Split Type | Forward |
| Split Ratio | 1.15 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 3 |